When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular.
Last week the...
According to an SEC filing, mail-order personal genome service and research company 23andMe has raised $79 million, in a round the company hopes will top out at $150 million. The investors are undisclosed and 23andMe declined to comment while the round was ongoing.
This is the company's largest single funding raise to date. It brings its total funding to $190 million plus a $1.4 million research...
Pfizer Head of Clinical Innovation Craig Lipset
In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail. But that trial was cancelled due to a failure to recruit enough participants, and a promised mulligan never emerged.
Craig Lipset, Pfizer's Head of Clinical Innovation, said at the...
A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians.
The survey was conducted by Ipsos in collaboration with the National Council on Patient Information and Education (NCPIE) and Pfizer.
The survey found that 64 percent of respondents said they could be making more decisions about their health and...
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower.
The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
Misfit Flash, one of the devices that will be used in the study.
AARP has launched a new research initiative, called Project Catalyst, where the organization will work with partners including Pfizer, UnitedHealthcare, and Georgia Tech to promote an increased focus on users over 50 in digital health research and development. The first project of the new initiative, focused on sleep and activity...
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round.
The Nottingham, England-based company...
San Mateo-based startup Mousera raised $8.8 million from undisclosed investors, according to a report from MedCity News. The company cryptically states on its website that it's "accelerating medical advancement by bringing 21st century technology into living systems research".
Although the company hasn't released investor names, former Pfizer CEO and Lux Capital Venture Partner Jeff Kindler was...
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies.
According to R2G, the top pharma companies have 65 apps in the Apple and...
TapTrak's forthcoming clinical trials app.
Medical micro-journaling startup tapTrak has formally hired pharma veteran Efren Olivares, a hire that signals the company's upcoming expansion into the pharma space.
New York City-based tapTrak, which raised $390,000 in seed funding last July, began its life in 2011 as a consumer-focused quantified self app, to make it easy for people to track and...
.jpeg?itok=HF3iI7dj "Person answering their front door and getting a delivery from another person")
